case presentation summer pathology seminar iap 2012 senec, slovak republic june 8-9, 2012
DESCRIPTION
Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012. Fredrik Petersson MD, PhD Associate Professor Senior Consultant Department of Pathology National University of Singapore National University Health System. Clinical History. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/1.jpg)
Case PresentationSummer Pathology Seminar IAP 2012
Senec, Slovak Republic June 8-9, 2012
Fredrik Petersson MD, PhD
Associate Professor
Senior Consultant
Department of Pathology
National University of Singapore
National University Health System
![Page 2: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/2.jpg)
![Page 3: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/3.jpg)
Clinical History
• A 54 year old Chinese man developed progressively worsening stridor over the course of a few months.
• A CT scan revealed an subglottic laryngeal lesion measuring 1.5 cm located just below the vocal cords with partial obstruction of the lumen.
• A biopsy of the lesion was performed reported as a “soft tissue
sarcoma with smooth muscle differentiation” (not by me).
• Pre-operative chest x-rays, ultra-sound examination of the abdomen and MRI of the brain did not show any concurrent tumors.
• A total laryngectomy was performed.
![Page 4: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/4.jpg)
![Page 5: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/5.jpg)
![Page 6: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/6.jpg)
2. Divider•Introducing new topic Histology
![Page 7: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/7.jpg)
Cricoid
Tumor
Tumor
Lymph node
Tumor composed of two different components
![Page 8: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/8.jpg)
Well circumscribed, unencapsulated
![Page 9: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/9.jpg)
![Page 10: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/10.jpg)
Slit-like blood vessels
![Page 11: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/11.jpg)
Fascicles of spindle cells with bland nuclear features
![Page 12: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/12.jpg)
Two sharply separated components
![Page 13: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/13.jpg)
![Page 14: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/14.jpg)
Cellular component – primitive appearing round cells
![Page 15: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/15.jpg)
Focal nuclear atypia
![Page 16: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/16.jpg)
Light Microscopic Features - Summary
• Biphasic non-encapsulated, well circumscribed tumor with no invasion into cartilage.
• (1) Moderately cellular spindle cell component with no significant nuclear atypia or mitotic activity.
• Presence of blood vessels.
• (2) A primitive, small round cell component featuring focal nuclear atypia (and mitotic activity).
• (1) and (2) sharply separated.
![Page 17: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/17.jpg)
3. Divider•Introducing new topic Immunohistochemistry
![Page 18: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/18.jpg)
SMA positive in both components
![Page 19: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/19.jpg)
SMA spindle cells
![Page 20: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/20.jpg)
SMA
![Page 21: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/21.jpg)
SMA round cell component
![Page 22: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/22.jpg)
SMA
![Page 23: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/23.jpg)
Desmin
![Page 24: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/24.jpg)
CD34 highlighted abundant vessels also in the cellular component
![Page 25: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/25.jpg)
CD34 – spindle cell component
![Page 26: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/26.jpg)
CD3 – Intratumoral T-cells
![Page 27: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/27.jpg)
CD3
![Page 28: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/28.jpg)
Immunohistochemistry - Summary
• Both components strongly positive for SMA and negative for desmin.
• Prominent vasculature (also in the primitive small round cell component).
• Intratumoral T-cells.
• Negative for S100 protein, CD34 and cytokeratins.
![Page 29: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/29.jpg)
Diagnosis?
![Page 30: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/30.jpg)
Additional History
• The patient had developed chronic renal failure and had a renal transplant 14 years prior to the development of the laryngeal tumor.
• The patient was on an immunosuppressive drugs; cyclosporine A and azathioprine.
![Page 31: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/31.jpg)
Magic Bullet…
![Page 32: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/32.jpg)
EBV (EBER) in situ hybridization
![Page 33: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/33.jpg)
EBER – strongly positive in both components
![Page 34: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/34.jpg)
EBER
![Page 35: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/35.jpg)
EBER
![Page 36: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/36.jpg)
EBER
![Page 37: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/37.jpg)
Diagnosis: EBV associated Smooth Muscle Tumor
![Page 38: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/38.jpg)
![Page 39: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/39.jpg)
• I found that the patient had a previously diagnosed cutaneous angioleiomyoma.
• Which I retrieved and reviewed.
Working Up the Case…..
![Page 40: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/40.jpg)
![Page 41: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/41.jpg)
Fascicles of bland myoid cells
![Page 42: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/42.jpg)
Medium sized blood vessels
![Page 43: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/43.jpg)
Fascicles of myoid cells blending imperceptively with blood vessel
![Page 44: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/44.jpg)
![Page 45: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/45.jpg)
Morphology consistent withAngioleiomyoma/Vascular Leiomyoma
But…..
![Page 46: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/46.jpg)
EBV (EBER) ISH – strongly positive
![Page 47: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/47.jpg)
EBV associated SMT
Revised DX
![Page 48: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/48.jpg)
![Page 49: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/49.jpg)
EBV SMT - History
• In 1970 and 1971, smooth muscle tumors associated with immunosuppression were first reported.
• In the 1980s, there were steadily increasing numbers of patients with AIDS and transplant related immunosuppression and smooth muscle tumors, variably considered as leiomyomas or leiomyosarcomas.
• In 1994/95 the causative link between these tumors and Epstein-Barr virus was established.*
• Have also been associated with autoimmune diseases and common variable immunodeficiency syndrome .
* McClain KL et al. N Engl J Med. 1995 Jan 5;332(1):12-8.
* Prevot S et al. Virchows Arch. 1994;425(3):321-5.
![Page 50: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/50.jpg)
EBV SMT – Anatomical Distribution
• EBV-SMTs have been described in a wide variety of anatomical locations and are frequently multifocal.
• Liver, spleen, gall bladder, tonsils, palate, nasopharynx, skin, pharynx, cribriform plate, orbita, larynx, mesentery, lung, iris, bone, skin, brain, meninges, spinal cord, common bile duct, myocardium, lymph nodes, adrenals, breast, pleura, urinary bladder, stomach, duodenum, gallbladder, spleen, small bowel, pericardium and bronchi.
![Page 51: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/51.jpg)
EBV SMT – Anatomical Distribution
• The four most commonly reported sites in a review paper by Purgina et al on 64 cases of HIV-associated EBV- SMTs were CNS (brain and spinal cord; 20%), soft tissue (18%), lung (10%) and liver (9%).
![Page 52: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/52.jpg)
EBV SMT – Morphological Spectrum
• The classical description of these tumors include: (1) A relatively monomorphic population of spindle cells arranged in short, interlacing fascicles and (2) A primitive round cell population that may appear intermixed with (1) or as separate/discrete nodules.
• Note: (2) is only present in approximately 50% of cases.
• A variably prominent vascular component is frequently present.
![Page 53: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/53.jpg)
EBV SMT – Morphological Spectrum
• May be well circumscribed (with or without a capsule) or may display poor circumscription with destructive invasion into the surrounding tissues.
• The cellularity is variable and both fibrosis and hyaliniziation may be present.
• In most cases, an intratumoral infiltrate of T- lymphocytes is present.
• Mitotic activity is mostly low (<3/10 HPF), but may on occasion be brisk (with up to up to 23 mitotic figures/ 10 HPF reported ).
![Page 54: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/54.jpg)
EBV SMT - Histogenesis
• The cell of origin for EBV-SMT is unclear.
• Some investigators have noted that minute EBV-SMTs have had a close relationship to the muscle cells of small caliber vessels.
• In one study the authors claimed to have noted dysplastic (?) changes of the cells in vessels walls, thus raising the possibility that this may represent a precursor lesion.
• On the other hand, the presence of EBV positive spindle cells within the vessel walls in the tumors, could well be attributed to invasion/replacement of the native smooth muscle cells of the vessel wall by tumor cells.
![Page 55: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/55.jpg)
EBER -ISH
H-Caldesmon
![Page 56: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/56.jpg)
EBV (EBER) ISH
![Page 57: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/57.jpg)
EBV SMT: Immunohistochemitry
• EBV-SMTs express smooth muscle actin, h-caldesmon and muscle specific actin.
• Desmin is variably positive, but not uncommonly with a weak
and focal staining.
• Negativity for desmin is most consistently seen in the small primitive round cell component.
![Page 58: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/58.jpg)
EBV SMT – Biology
• That EBV-SMTs are clonal proliferations has been firmly established in several studies.
• The frequent multifocality most likely represents different transforming events, i.e. separate tumors and not metastasis.
• There appears to be no relation between classical histopathological features of malignancy (nuclear atypia, mitotic activity etc) and prognosis (which appears more closely related to the site of involvement and the immune status of the patient).
![Page 59: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/59.jpg)
EBV SMT - Differential Diagnoses
• The list of differential diagnoses is wide and varies with site and morphology of the particular EBV-SMT.
• Some entities that need to be considered are:
• Somatic or uterine leiomyomas/leiomyosarcomas • Cellular Schwannoma • MPNST• Meningioma• Inflammatory myofibroblastic tumor• Infective (mycobacterial, cryptococcal ) spindle cell pseudotumors• Inflammatory, pseudotumor-like, EBV+ follicular dendritic cell
sarcoma• Myofibroma/myofibromatosis• Myopericytoma• Glomangiopericytoma• GIST• SFT- Hemangiopericytoma• Endometrial stromal sarcoma with myoid differentiation.
![Page 60: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/60.jpg)
• There exist no randomized controlled clinical trials and most of the data on this topic is based on case reports and small series.
• Surgical resection, reduction of immunosuppressive therapy and antiviral treatment are all modalities that have been used either in isolation or in various combinations.
• Cytotoxic chemotherapy and radiotherapy appear to be
ineffective.
EBV SMT - Treatment
![Page 61: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/61.jpg)
EBV SMT - Treatment
• Few cases of AIDS associated EBV-SMT have shown stable disease and even regression of tumors with increased CD4 cell counts related to highly active antiretroviral therapy (HAART).
![Page 62: Case Presentation Summer Pathology Seminar IAP 2012 Senec, Slovak Republic June 8-9, 2012](https://reader038.vdocuments.us/reader038/viewer/2022103102/56815a05550346895dc75150/html5/thumbnails/62.jpg)
Thank you for your attention.
Questions?